Clinical Guidance for COVID-19 Vaccination | CDC
https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html
OverviewOverview of COVID-19 vaccinationCOVID-19 vaccination guidance for people who are not moderately or severely immunocompromisedCOVID-19 vaccination guidance for people who are moderately or severely immunocompromisedTiming, spacing, age transitions, and simultaneous administrationInterchangeability of COVID-19 vaccinesVaccination and SARS-CoV-2 laboratory testingPatient counselingContraindications and precautionsReporting of vaccine adverse eventsmRNA COVID-19 vaccinesChildren ages 6 months–4 years should receive all doses of an mRNA COVID-19 vaccine from the same manufacturer (i.e., homologous dosing); this includes children who are moderately or severely immunocompromised and those who are not. People ages 5 years and olde mRNA COVID-19 vaccinesChildren ages 6 months–4 years should receive all doses of an mRNA COVID-19 vaccine from the same manufacturer (i.e., homologous dosing); this includes children who are moderately or severely immunocompromised and those who are not. People ages 5 years and older who are … For people who receive 1 Moderna and 1 Pfizer-BioNTech vaccine dose, complete the initial vac…•Children ages 6 months–4 years who are not moderately or severely immunocompromised should follow a 3-dose schedule. A third dose of either updated (2023–2024 Formula) Moderna vaccine or updated (2023–2024 Formula) Pfizer-BioNTech vaccine should be administered at le…
mRNA COVID-19 vaccinesChildren ages 6 months–4 years should receive all doses of an mRNA COVID-19 vaccine from the same manufacturer (i.e., homologous dosing); this includes children who are moderately or severely immunocompromised and those who are not. People ages 5 years and older who are …
For people who receive 1 Moderna and 1 Pfizer-BioNTech vaccine dose, complete the initial vac…•Children ages 6 months–4 years who are not moderately or severely immunocompromised should follow a 3-dose schedule. A third dose of either updated (2023–2024 Formula) Moderna vaccine or updated (2023–2024 Formula) Pfizer-BioNTech vaccine should be administered at le…
DA: 15 PA: 13 MOZ Rank: 11
